Analysis of Chronic Myelogenous Leukemia Including Balanced BCR/ABL1 Translocations by Microarray Analysis

被引：0

作者：

Schultz, R. ^{[1
]}

Ballif, C. ^{[1
]}

McDaniel, L. ^{[1
]}

Brown, T. ^{[2
]}

Campbell, L. ^{[3
]}

Wall, M. ^{[3
]}

Han, J. ^{[4
]}

Surti, U. ^{[5
]}

Kolquist, K. ^{[6
]}

Ouahchi, K. ^{[6
]}

Shaffer, L. G. ^{[1
]}

Slovak, Ml ^{[1
]}

机构：

[1] Signature Genom Labs, Spokane, WA USA

[2] CSI Labs, Alpharetta, GA USA

[3] St Vincent Hosp Melbourne, Fitzroy, Vic, Australia

[4] Dong A Univ, Coll Med, Pusan, South Korea

[5] Univ Pittsburgh, Pittsburgh, PA USA

[6] Pathol Associated Med Lab, Spokane, WA USA

来源：

JOURNAL OF MOLECULAR DIAGNOSTICS | 2010年 / 12卷 / 06期

关键词：

D O I：

暂无

中图分类号：

R36 [病理学];

学科分类号：

100104 ;

摘要：

引用

页码：868 / 868

页数：1

共 50 条

[31] The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemia
Jessica Fredericks
Ruibao Ren
Frontiers of Medicine, 2013, 7 : 452 - 461
[32] Re-evaluating the role of BCR/ABL in chronic myelogenous leukemia
Ross, Theodora S.
Mgbemena, Victoria E.
MOLECULAR & CELLULAR ONCOLOGY, 2014, 1 (03)
[33] BCR-ABL in chronic myelogenous leukemia - How does it work?
Goldman, John M.
Melo, Junia V.
ACTA HAEMATOLOGICA, 2008, 119 (04) : 212 - 217
[34] Molecular monitoring of the treatment of patients with BCR/ABL (+) chronic myelogenous leukemia
Ruiz-Argüelles, GJ
López-Martínez, B
Ramírez-Cabrera, JM
Reyes-Núñez, V
Rodríguez-Cedeño, HM
Garcés-Eisele, J
REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 2001, 53 (03): : 235 - 239
[35] Bcr-Abl and inhibition of apoptosis in chronic myelogenous leukemia cells
J. L. Fernandez-Luna
Apoptosis, 2000, 5 : 315 - 318
[36] BCR-ABL tyrosine kinase inhibitors for chronic myelogenous leukemia
Schiffer, Charles A.
NEW ENGLAND JOURNAL OF MEDICINE, 2007, 357 (03): : 258 - 265
[37] Is another Bcr-Abl inhibitor needed for chronic myelogenous leukemia?
Sausville, EA
CLINICAL CANCER RESEARCH, 2003, 9 (04) : 1233 - 1234
[38] Continuous therapy response references for BCR::ABL1 monitoring in pediatric chronic myeloid leukemia
Christian Volz
Thomas Zerjatke
Andrea Gottschalk
Sabine Semper
Meinolf Suttorp
Ingmar Glauche
Manuela Krumbholz
Markus Metzler
Scientific Reports, 13
[39] The role of RAS effectors in BCR/ABL induced chronic myelogenous leukemia
Jessica Fredericks
Ruibao Ren
Frontiers of Medicine, 2013, 7 (04) : 452 - 461
[40] MOLECULAR CONSEQUENCES OF THE BCR-ABL TRANSLOCATION IN CHRONIC MYELOGENOUS LEUKEMIA
SAWYERS, CL
LEUKEMIA & LYMPHOMA, 1993, 11 : 101 - 103

← 1 2 3 4 5 →